An association between reduced function CYP2C9*2 and CYP2C9*3 alleles with higher risk of SU related hypoglycemia was reported confirming earlier functional and pharmacokinetic data (Ragia et al., 2009; Gökalp et al., 2011). Here, CYP2C9 is linked to Hypoglycemia.